[c09aa8]: / clusters / 9knumclustersv2 / clust_1294.txt

Download this file

68 lines (67 with data), 2.9 kB

 1
 2
 3
 4
 5
 6
 7
 8
 9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
Male or female patients aged ? years
Male subjects must:
Male or female patients aged ? years.
Male or female aged ? years
Male or female subjects
Adult male or female participants aged >= years (Japan) or >= years (United States).
Male or female patients aged ? years at time of informed consent;
Male or female aged ? years;
Male or female participant
Male or female aged ? years.
Male or female, aged at least years.
Male patients
Gender: male and female
Male/female sterilization
All male and female subjects must follow all requirements defined in the Pregnancy Prevention Program.
Male and female subjects
Male or female subjects aged greater than or equal to (>=) years
Male and female subjects
Male patients.
Male subjects must :
Male or female subjects aged ? years
Male or non-pregnant, non-breastfeeding female at least years of age. Patients aged at ~ years may be recruited but only at the site principle investigator's request and subject to IRB approval.
Male or Female
Male or female patients aged - years.
Male or female subjects aged greater than or equal to (>=) years
Male or female subjects aged ? years
Subjects may be male or female, and must be aged =/> years on the date of signing the informed consent form.
Male or female subjects aged ? years
Male or female subjects aged >/= years.
Patient is male or female aged ? years.
Male or female, aged at least years.
Male or non-pregnant female
Sex: male or female.
Male or female subjects aged greater than or equal to (>=) years
Male and female subjects aged greater than years
Male or female patients aged >/= years old
Male subjects must:
Male or female participants aged ? years at the time of screening
Male or female subjects aged > years
Male and female subjects aged to years, inclusive.
Male or female aged ? years
Male or female subjects aged ? years (or country-specific legal age of maturity, if > years)
Male or female, and:
Male or female
Male or female subjects aged =/> years
Male and female subjects
Male or Female (non-pregnant)
Male or female subjects aged >/= years
Male or female aged ? years
Male or female subjects aged >/= years
Male and female patients aged ? years.
Male or female participants aged to < years ( to < years for Hodgkin lymphoma [HL])
Male or female aged years; a female is eligible to enter and participate in the study if she is:
Male Patients:
Male or female patients aged > years
Male gender
Male patients
Male and female patients aged to years, inclusive;
Male subjects must:
Male subjects must:
Male or Female
Men with a history of at least one male sexual partner \r\n* Men is defined as those documented male at birth (including male-to-female transgendered persons)
Participant can be a male or a non-pregnant female
Male patients
Male or female patients
The patient is male
Male or female aged -